Clear Street downgrades Janux Therapeutics (JANX) to Hold, slashing its price target amid concerns over a lack of durability data for its lead candidate JANX007 and rising competitive pressures, despite a recent major collaboration deal with Bristol Myers Squibb.
The cryptocurrency wallet provider Exodus Movement reports disciplined capital management with a debt-free balance sheet and 1.5 million monthly users, even as BTIG trims its price target citing cautious volume outlook.
Despite reporting revenue and earnings that topped Wall Street forecasts, Triumph Financial's stock fell post-earnings. While management pointed to strength in its payments network and cost controls, analysts on the call focused on persistent challenges in the freight sector and the sustainability of margins.
The Kospi index plunged over 5% in its sharpest drop since April, halting program trading and dragging down chip giants Samsung and SK Hynix. The selloff, fueled by global risk-off sentiment and doubts over AI spending, tests the resilience of one of the world's hottest equity markets.
Two of the largest known Ethereum holders, BitcoinOG and Trend Research, have strategically sold a combined $371 million worth of ETH to repay loans on the Aave protocol. This voluntary deleveraging, distinct from over $140 million in automated liquidations processed by Aave, highlights a shift towards caution among major crypto players amid market volatility.
The decentralized finance protocol has publicly identified wallets linked to a weekend exploit, warning of criminal and civil action if funds are not returned within 72 hours, as security firms point to a critical validation flaw.
Electronic Arts (EA) is set to report its fourth-quarter financial results after Tuesday's market close, with Wall Street anticipating a significant revenue rebound. The report comes at a pivotal moment for the gaming sector, which has faced mixed signals from consumers and a volatile market.
President Trump's nomination of former Fed Governor Kevin Warsh to lead the central bank sets the stage for a pivotal confirmation battle, raising questions about monetary policy direction and the erosion of the Fed's political firewall.
Apple shares edged higher following a robust Q1 earnings report headlined by record iPhone revenue, yet the muted gains reflect Wall Street's growing focus on looming supply constraints and the company's strategic pivot to artificial intelligence.
Wall Street firms are increasingly optimistic about Datadog's (DDOG) trajectory toward 2026, with Stifel upgrading the stock to Buy and highlighting strong Q4 expectations, even as the company navigates sector-wide pricing and competitive pressures.
After the COVID-19 windfall subsided, Pfizer CEO Albert Bourla is steering the pharmaceutical giant into a high-stakes, $23 billion pivot to cancer research. Facing a looming patent cliff and plummeting vaccine revenue, Bourla is betting on scientific innovation to secure the company's future—and redefine cancer treatment.
The Federal Reserve's decision to hold interest rates steady signals a strategic pause, not an end to its easing cycle. We break down the immediate and future impacts on everything from credit cards to the housing market.
Medical device maker ResMed (RMD) reported fourth-quarter revenue of $1.42 billion, an 11% year-over-year increase that surpassed Wall Street forecasts. Non-GAAP earnings per share reached $2.81, also topping analyst expectations.
Valley National Bancorp (VLY) reported fourth-quarter revenue and profit that topped Wall Street forecasts, driven by robust core deposit growth and disciplined balance sheet management. The regional bank's leadership pointed to strategic tech investments and commercial loan demand as key pillars for its 2025 outlook.
The floral and gift e-commerce giant 1-800-FLOWERS reported a 9.5% year-over-year revenue decline to $702.2 million for its fiscal fourth quarter, aligning with Wall Street's subdued expectations. However, disciplined cost management fueled a significant earnings beat, with non-GAAP EPS of $1.20 surging 39.5% above estimates.
Trane Technologies (TT) surpassed Wall Street expectations for Q4 2025, driven by surging demand in commercial HVAC systems and data center infrastructure. The company reported revenue of $5.14B, up 5.5% year-over-year, with earnings per share of $2.86. Management expressed confidence for 2026, citing a record order backlog.
ARK Invest's Cathie Wood made a significant $26 million investment in Broadcom stock last week, highlighting a strategic pivot towards AI infrastructure amid portfolio reshuffling. The move follows Broadcom's blockbuster earnings and comes as Wall Street maintains a bullish outlook on the chipmaker.
A former investment advisor with ties to major Wall Street firms has been sentenced to six years behind bars for orchestrating a million-dollar fraud scheme, using client funds to finance a luxury lifestyle that included high-end cars and country club memberships.
Clinical-stage biopharma Alumis Inc. (ALMS) is gaining significant Wall Street attention after its lead drug candidate, envudeucitinib, successfully met all endpoints in key Phase 3 trials for plaque psoriasis, prompting multiple analyst upgrades and optimistic price targets.
Wall Street analysts have issued a dramatic upgrade to revenue projections for Americas Gold and Silver Corp., forecasting a surge to $383 million by 2026 and signaling accelerated growth far beyond industry peers.
